Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company
What size range is anticipated for the Software As A Medical Device (SaMD) Market from 2026 to 2030?
The software as a medical device (samd) market size has experienced substantial expansion in recent years. It is anticipated to increase from $38.02 billion in 2025 to $47.26 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 24.3%. This historical growth can be linked to the rise of telemedicine adoption, increased smartphone penetration, significant digital health funding, clearer regulatory guidance, and a heightened demand for remote care services.
The market size for software as a medical device (samd) is projected to see substantial growth in the coming years. It is anticipated to expand to $120.54 billion by 2030, achieving a compound annual growth rate (CAGR) of 26.4%. This forecasted growth can be attributed to the broadening of virtual care, advancements in software-driven diagnostics, the emergence of cloud healthcare platforms, the implementation of outcome-based reimbursement, and ongoing hospital software modernization. Key trends during this period are expected to include the expansion of clinical decision support software, the proliferation of remote diagnostic applications, increased regulatory validation for medical software, the adoption of subscription-based samd business models, and enhanced integration with electronic health records.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12446&type=smp
What Drivers Are Affecting Demand In The Software As A Medical Device (SaMD) Market?
The rising occurrence of chronic illnesses is anticipated to propel the expansion of the software as a medical device (SaMD) market in the future. These are enduring health conditions that typically advance slowly, such as diabetes, heart disease, and arthritis, often necessitating ongoing medical attention and lifestyle management to control symptoms and prevent complications. The increase in chronic diseases is largely attributable to unhealthy lifestyles, including poor diet, physical inactivity, and smoking, which elevate the risk of conditions like diabetes, heart disease, and obesity. Software as a medical device (SaMD) supports chronic disease management by enabling continuous tracking of patient health metrics, facilitating early identification of complications. It improves therapeutic outcomes by delivering personalized insights and bolstering remote care, thus diminishing the requirement for frequent hospital visits. For instance, in June 2024, the National Health Service, a UK-based government department, reported that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, marking an 18% increase from 3,065,825 cases in 2022. Consequently, the growing prevalence of chronic diseases is driving the growth of the software as a medical device (SaMD) market.
Which Segment Groups Are Influencing The Software As A Medical Device (SaMD) Market?
The software as a medical device (samd) market covered in this report is segmented –
1) By Device Type: Wearable Device, PCs And Laptop, Smartphone And Tablets
2) By Deployment Method: Cloud-Based, On-Premise
3) By Application: Diagnostic, Clinical Management
Subsegments:
1) By Wearable Devices: Smartwatches With Health Monitoring Functions, Fitness Trackers, Wearable ECG And Blood Pressure Monitors
2) By PCs And Laptops: Medical Diagnostic Software, Clinical Decision Support Software, Telemedicine Platforms
3) By Smartphone And Tablets: Mobile Health (mHealth) Apps, Remote Patient Monitoring Software, Diagnostic Imaging Apps
How Are Emerging Trends Affecting The Progression Of The Software As A Medical Device (SaMD) Market?
Major companies operating in the software as a medical device (SaMD) market are intensifying their focus on launching advanced software solutions, such as SOMNUM, to secure a competitive advantage. SOMNUM is a sleep disease analysis software that incorporates the latest AI research trends alongside diagnostic algorithms based on multi-channel sleep biosignal data rather than video images. For instance, in September 2023, HoneyNaps Co. Ltd., a South Korea-based software entity, was granted approval by the United States Food and Drug Administration (USFDA) for its SOMNUM software. This application utilizes deep learning-based AI to perform real-time analysis of various sleep biosignals, including electroencephalograms, electrooculograms, electromyograms, electrocardiograms, respiratory airflow and effort, and oxygen saturation. The software is engineered to provide more accurate and sophisticated readings than conventional methods, and it can shorten the analysis of patient sleep data to under five minutes.
Who Are The Major Companies Operating In The Software As A Medical Device (SaMD) Market?
Major companies operating in the software as a medical device (samd) market are Apple Inc., Abbott Laboratories, Siemens Healthcare GmbH, GE HealthCare Technologies Inc., Roche Diagnostics, Cerner Corporation, Philips Medical Systems Ltd., Dexcom Inc., Carl Zeiss Meditec AG, Nihon Kohden Corporation, Viz.ai Inc., S3 Connected Health, Arterys Inc., BrightInsight Inc., Agfa HealthCare Corp., iSchemaView Inc., VitalConnect Inc., Volpara Health Technologies, Greenfinch Technology Ltd., MaxQ AI Ltd., IDx Technologies Inc.
Access The Complete Report For Deeper Market Insights:
Which Regions Are Poised For Strategic Growth In The Software As A Medical Device (SaMD) Market?
North America was the largest region in the software as a medical device (SaMD) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the software as a medical device (samd) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Software As A Medical Device (SaMD) Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=12446&type=smp
Browse Through More Reports Similar to the Global Software As A Medical Device (SaMD) Market 2026, By The Business Research Company
Medical Equipment Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/medical-equipment-global-market-report
Medical And Diagnostic Laboratory Services Global Market Report 2026
Medical Aesthetics Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/medical-aesthetics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company